Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Randal H. Henderson, Curtis Bryant, Bradford S. Hoppe, R. Charles Nichols, William M. Mendenhall, Stella Flampouri, Zhong Su, Zuofeng Li, Christopher G. Morris & Nancy P. Mendenhall. (2017) Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer. Acta Oncologica 56:7, pages 963-970.
Read now
Read now
Morten Høyer, Ludvig P. Muren & Bengt Glimelius. (2015) The evolution of radiotherapy techniques in the management of prostate cancer. Acta Oncologica 54:6, pages 821-824.
Read now
Read now
Thomas P. Kole, R. Charles Nichols, Song Lei, Binbin Wu, Soon N. Huh, Christopher G. Morris, Sang Lee, Michael Tong, Nancy P. Mendenhall, Anatoly Dritschilo & Sean P. Collins. (2015) A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncologica 54:6, pages 825-831.
Read now
Read now
Articles from other publishers (23)
Yuki Narita, Takahiro Kato, Yojiro Ishikawa, Kimihiro Takemasa, Hisashi Yamaguchi & Masao Murakami. (2023) Optimal Bladder Volume for Hypofractionated Proton Therapy in Each Localized Prostate Cancer Risk Group. Cureus.
Crossref
Crossref
Taiki Takaoka, Takeshi Yanagi, Atsushi Tanaka, Yuka Kiriyama, Yoshihiro Tanaka, Takuhito Kondo, Seiya Takano, Shinsei Takahashi, Yuta Shibamoto, Natsuo Tomita & Akio Hiwatashi. (2023) Acute genitourinary toxicity of pencil beam scanning proton therapy for localized prostate cancer: utility of the transition zone index and average urinary flow rate in predicting acute urinary retention. Japanese Journal of Clinical Oncology 53:5, pages 419-428.
Crossref
Crossref
Cameron S. ThorpeMDMD, Ronik S. BhangooMDMD, Justin D. AndersonMDMD, Jiajian (Jason) ShenPhDPhD & Carlos E. VargasMDMD. 2022. Principles and Practice of Particle Therapy. Principles and Practice of Particle Therapy
383
410
.
Alexandre Santos, Scott Penfold, Peter Gorayski & Hien Le. (2022) The Role of Hypofractionation in Proton Therapy. Cancers 14:9, pages 2271.
Crossref
Crossref
Darren M. C. Poon, Stephen Wu, Leon Ho, Kin Yin Cheung & Ben Yu. (2022) Proton Therapy for Prostate Cancer: Challenges and Opportunities. Cancers 14:4, pages 925.
Crossref
Crossref
Dorota Maria Borowicz, Konstantin N. Shipulin, Gennady V. Mytsin, Agnieszka Skrobała, Piotr Milecki, Victor N. Gayevsky, Vladimir Vondráček & Julian Malicki. (2021) Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy. Journal of Personalized Medicine 11:12, pages 1311.
Crossref
Crossref
Meixuan Li, Xiuxia Li, Liang Yao, Xue Han, Wenlong Yan, Yujun Liu, Yiwen Fu, Yakun Wang, Min Huang, Qiuning Zhang, Xiaohu Wang & Kehu Yang. (2021) Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Eun Ji Hwang, Peter Gorayski, Hien Le, Gerard G Hanna, Liz Kenny, Michael Penniment, Jacqueline Buck, David Thwaites & Verity Ahern. (2020) Particle therapy tumour outcomes: An updated systematic review. Journal of Medical Imaging and Radiation Oncology 64:5, pages 711-724.
Crossref
Crossref
Suphalak Khachonkham, Elisabeth Mara, Sylvia Gruber, Rafael Preuer, Peter Kuess, Wolfgang Dörr, Dietmar Georg & Monika Clausen. (2020) RBE variation in prostate carcinoma cells in active scanning proton beams: In-vitro measurements in comparison with phenomenological models. Physica Medica 77, pages 187-193.
Crossref
Crossref
Boram Ha, Kwan Ho Cho, Kang Hyun Lee, Jae Young Joung, Yeon-Joo Kim, Sung Uk Lee, Hyunjung Kim, Yang-Gun Suh, Sung Ho Moon, Young Kyung Lim, Jong Hwi Jeong, Haksoo Kim, Weon Seo Park & Sun Ho Kim. (2019) Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation. Radiation Oncology 14:1.
Crossref
Crossref
Amardeep S. Grewal, Caitlin Schonewolf, Eun Jeong Min, Hann-Hsiang Chao, Stefan Both, Sarah Lam, Susan Mazzoni, Justin Bekelman, John Christodouleas & Neha Vapiwala. (2019) Four-Year Outcomes From a Prospective Phase II Clinical Trial of Moderately Hypofractionated Proton Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 105:4, pages 713-722.
Crossref
Crossref
Mercy Ofuya, Lucy McParland, Louise Murray, Sarah Brown, David Sebag-Montefiore & Emma Hall. (2019) Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy. Clinical and Translational Radiation Oncology 19, pages 17-26.
Crossref
Crossref
William C. Jackson, Jessica Silva, Holly E. Hartman, Robert T. Dess, Amar U. Kishan, Whitney H. Beeler, Laila A. Gharzai, Elizabeth M. Jaworski, Rohit Mehra, Jason W.D. Hearn, Todd M. Morgan, Simpa S. Salami, Matthew R. Cooperberg, Brandon A. Mahal, Payal D. Soni, Samuel Kaffenberger, Paul L. Nguyen, Neil Desai, Felix Y. Feng, Zachary S. Zumsteg & Daniel E. Spratt. (2019) Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. International Journal of Radiation Oncology*Biology*Physics 104:4, pages 778-789.
Crossref
Crossref
Arpit M. Chhabra, Melissa A. Frick, Tejan Diwanji, Jason K. Molitoris & Charles B. SimoneIIII. 2019. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
217
233
.
Ting WangMinmin JiangYanjun RenQingmin LiuGang ZhaoChenjian CaoHongmei Wang. (2018) Health-Related Quality of Life of Community Thyroid Cancer Survivors in Hangzhou, China. Thyroid 28:8, pages 1013-1023.
Crossref
Crossref
Koichiro Nakajima, Hiromitsu Iwata, Hiroyuki Ogino, Yukiko Hattori, Shingo Hashimoto, Mikiko Nakanishi, Toshiyuki Toshito, Yukihiro Umemoto, Shoichiro Iwatsuki, Yuta Shibamoto & Jun-etsu Mizoe. (2017) Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer. International Journal of Clinical Oncology 23:2, pages 353-360.
Crossref
Crossref
Marco Schwarz & Silvia Molinelli. (2016) What can particle therapy add to the treatment of prostate cancer?. Physica Medica 32:3, pages 485-491.
Crossref
Crossref
Neha Vapiwala, Bradford Hoppe & Howard Sandler. (2015) Re: Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam. Journal of Urology 194:5, pages 1507-1509.
Crossref
Crossref
Wayne Newhauser, Rui Zhang, Timothy Jones, Annelise Giebeler, Phillip Taddei, Robert Stewart, Andrew Lee & Oleg Vassiliev. (2015) Reducing the Cost of Proton Radiation Therapy: The Feasibility of a Streamlined Treatment Technique for Prostate Cancer. Cancers 7:2, pages 688-705.
Crossref
Crossref
Yeon-Joo Kim, Kwan Ho Cho, Hong Ryull Pyo, Kang Hyun Lee, Sung Ho Moon, Tae Hyun Kim, Kyung Hwan Shin, Joo-Young Kim, Young-kyung Kim & Se Byeong Lee. (2014) Radical prostatectomy versus external beam radiotherapy for localized prostate cancerRadikale Prostatektomie versus externe Strahlentherapie beim lokal begrenzten Prostatakarzinom. Strahlentherapie und Onkologie 191:4, pages 321-329.
Crossref
Crossref
Yoshiyuki Shioyama, Hiroshi Tsuji, Hiroaki Suefuji, Makoto Sinoto, Akira Matsunobu, Shingo Toyama, Katsumasa Nakamura & Sho Kudo. (2015) Particle radiotherapy for prostate cancer. International Journal of Urology 22:1, pages 33-39.
Crossref
Crossref
Thomas J. Pugh & Andrew K. Lee. (2014) Proton Beam Therapy for the Treatment of Prostate Cancer. The Cancer Journal 20:6, pages 415-420.
Crossref
Crossref
S. Supiot, G. Créhange, I. Latorzeff, P. Pommier, A. Paumier, E. Rio, G. Delaroche, S. Guérif, C. Catton, J. Martin & A. Lisbona. (2013) Hypofractionnement à visée curative dans le cancer de la prostate. Cancer/Radiothérapie 17:5-6, pages 349-354.
Crossref
Crossref